{
  "@context": "https://orbyd.app/schemas/dossier.v1.json",
  "ticker": "COTY",
  "name": "COTY INC",
  "url": "https://orbyd.app/dossiers/COTY/",
  "json_url": "https://orbyd.app/dossiers/COTY.json",
  "status": "DORMANT",
  "current_conviction": "LOW",
  "graded_conviction": null,
  "archetype": {
    "code": "a4",
    "n": 4
  },
  "current_thesis": "Distressed, highly-levered beauty turnaround (net debt ~$3.17B, ~3.3-3.4x) bouncing +23% off its ~$1.82 all-time low on the ~$400M Gucci license transition to Kering and cost-out. A de-lever story, but the ~Aug-19 Q4 print is the binary and 4.9% short interest is too light to squeeze — a countertrend rally, not an accelerating narrative.",
  "invalidation_trigger": "A daily close below $2.30 forfeits the bounce off the ~$1.82 June all-time low; a subsequent weekly close below $1.82 confirms downtrend resumption, and a Q4 print (~2026-08-19) showing net leverage back above 3.4x removes the de-levering catalyst.",
  "catalyst_date": "2026-08-19",
  "outcome": "OPEN",
  "outcome_date": null,
  "invalidation_fired": null,
  "themes": [
    "consumer-discretionary-rotation"
  ],
  "tags": [],
  "sources": [],
  "notes": [
    "Earnings blackout: avoid fresh size into ~2026-08-19 Q4/FY26 print (date estimated, not yet confirmed by company).",
    "Recent +22.8% six-day rally (into 2026-07-22) is a bounce off the ~$1.82 all-time low (2026-06-29) and is flagged as disconnected from fundamentals (Trefis).",
    "Short interest only ~4.9% (43.25M sh) — not a squeeze setup; treat sub-$3 handle as distressed, not a coiled short base.",
    "Structural risk: Gucci license transition to Kering (~$400M, 2026-07-07) removes a top prestige revenue stream while funding de-levering; Kering Beauté build-out is an ongoing license-clawback risk.",
    "Leadership overhang: interim CEO Markus Strobel (Executive Chairman) since 2026-07-02; no permanent CEO named.",
    "Guide anchors: FY26 adj EBITDA $838-848M, adj EPS ex-swap $0.33-0.35; Q4 adj EBITDA $85-95M, EPS breakeven to -$0.02."
  ],
  "body_markdown": "## Current Thesis\n\nCoty is a highly-levered prestige and mass beauty operator (Gucci and Burberry fragrance licenses, CoverGirl, Rimmel, Marc Jacobs, Sally Hansen) trading as a distressed turnaround, not a growth story. The late-July 2026 tape is a countertrend bounce: a ~22.8% six-day rally into 2026-07-22 (Trefis) off the ~$1.82 all-time low set 2026-06-29, retracing a sliver of a -60% one-year drawdown from the $5.33 high. What an investor is actually buying here is de-levering — the ~$400M Gucci beauty license transition back to Kering (announced 2026-07-07) is cash against a $3.17B net-debt load, and management has stated a path from ~3.3-3.4x net-debt/EBITDA toward ~2x. The counter is that the rally is explicitly disconnected from fundamentals (Q3 FY26 like-for-like sales -7%, revenue $1.28B, -1.3% YoY) and the whole trade re-prices on the Q4/full-year print due ~2026-08-19. This is a value-adjacent bounce inside a broken downtrend, not an accelerating narrative with peer cluster confirmation.\n\n## Bull Case\n\n- **De-lever catalyst is live.** The ~$400M Gucci beauty license transition back to Kering (announced 2026-07-07) delivers cash against $3.43B gross / ~$3.17B net debt; management targets net leverage toward ~2x from the current ~3.3-3.4x.\n- **Self-help cost-out underway.** The 2026-07-02 reorganization merged Prestige R&D and sustainability into supply chain under interim leadership, a simplification aimed at margin recapture after adj. Gross margin fell to 61.8% (-250bps YoY) in Q3 FY26.\n- **Product and flow flickers.** The Marc Jacobs Beauty relaunch and an index-inclusion move around 2026-06-12 gave the tape a near-term bid.\n- **Valuation reset with an open upside PT.** At roughly $2.55-$2.70 the stock sits below the ~$3.17-$3.70 consensus target, with Evercore ISI still at $7 Outperform (cut from $10) against Barclays' $3.50 Underweight — a wide dispersion that resolves violently on the print.\n- **Cash engine intact.** FY26 guidance still calls for ~$838-848M adjusted EBITDA and $0.33-0.35 adjusted EPS ex-equity-swap; the business is levered, not broken.\n- **Low-float optics.** A sub-$3 handle plus 43.25M shares short (~4.9%) means any clean beat gaps hard.\n\n## Bear Case\n\n- **Rally outran the business.** Trefis (2026-07-22) flags the +22.8% move as disconnected from fundamentals; revenue is down ~3.6% on a trailing-twelve-month basis.\n- **Weak Q3 FY26 core.** Revenue $1.28B (-1.3% YoY), like-for-like -7% on Middle East / travel-retail disruption, gross margin -250bps — demand is soft where it matters.\n- **Thin Q4 guide.** Q4 FY26 adjusted EBITDA guided $85-95M and adjusted EPS breakeven to -$0.02 (ex-swap); little cushion if beauty demand stays weak.\n- **Structural license attrition.** Losing Gucci removes a top prestige revenue stream, and Kering Beauté's in-house build makes further license clawbacks a portfolio risk, not a one-off.\n- **Leadership overhang.** Interim CEO Markus Strobel (Executive Chairman) per the 2026-07-02 release; no permanent CEO named — a search overhang on any re-rate.\n- **Balance sheet is the whole story.** $3.17B net debt at ~3.3-3.4x means any EBITDA slip re-rates leverage the wrong way and pressures the equity first.\n\n## Setup & Price Structure\n\n- Trading ~$2.55-$2.70 into 2026-07-23; StocksToTrade marks intraday support $2.53-$2.54 and resistance $2.70-$2.76.\n- Bounce structure: +22.8% over six sessions into 2026-07-22 off the ~$1.82 all-time low (2026-06-29), forming short-term higher lows / higher highs.\n- Longer frame remains broken: 52-week range $1.84-$5.33, -60% one-year, ~$2.4B market cap.\n- The grind is a countertrend recovery leg inside a primary downtrend. Reclaiming and holding above $2.76 opens air toward the ~$3.17 consensus; losing the $2.50 shelf re-exposes the June low.\n- For a momentum book, strength here is not the setup — it is a bounce off distressed lows into a binary print, so it reads as a small probe or a stand-aside until it either bases above $2.76 or the print de-risks the leverage.\n\n## Catalyst Calendar (next 30 days)\n\n- **~2026-08-19 (est.):** Q4 and full-year FY26 results and call — the binary. Bars to clear: Q4 adj. EBITDA $85-95M, FY $838-848M, and evidence that net leverage is trending toward 2x. Avoid fresh size into the print given -7% LFL momentum.\n\n## Elapsed catalysts\n\n- **Ongoing:** Gucci beauty license transition close (~$400M, announced 2026-07-07) — watch for explicit debt-paydown / cash-application confirmation. *(passed 33d ago)*\n- **Ongoing:** permanent-CEO announcement (interim since 2026-07-02) — a named operator could re-rate sentiment independent of the numbers. *(passed 38d ago)*\n\n## What Would Change Our Mind\n\n- **Upside confirmation:** sustained daily closes above $2.76 that hold the shelf, ideally after the ~2026-08-19 print, would flip this from a countertrend bounce into a base worth sizing.\n- **Fundamental confirmation:** an Aug-19 print showing net leverage ticking below 3.3x and like-for-like materially better than -7% would validate the de-lever thesis.\n- **Thesis break:** a daily close below $2.30 forfeits the June-low bounce; a subsequent weekly close below $1.82 confirms the downtrend has resumed. A print that pushes net leverage back above 3.4x removes the entire reason to own it.\n\n## Correlation Notes\n\n- Moves with beauty / consumer-discretionary peers — Estée Lauder (EL), e.l.f. (ELF), Ulta (ULTA); EL's own turnaround tape is the sector read-through.\n- Kering (KER.PA) is now both counterparty (Gucci license transition) and competitor (Kering Beauté); Kering's in-house beauty build is a standing license-attrition risk to Coty.\n- FX- and travel-retail-sensitive given large ex-US prestige exposure; Middle East demand was the explicit swing factor behind Q3 FY26's -7% LFL.\n- Rate-sensitive through the debt load — a tightening macro regime pressures highly-levered turnarounds disproportionately, so this trades with the credit backdrop as much as with beauty demand.",
  "first_seen": "2026-07-21",
  "last_analyzed": "2026-07-25T07:06:40+00:00",
  "last_synthesized": "2026-07-25",
  "last_update_source": "watchlist_research",
  "license": "Content © orbyd. Cite the canonical URL."
}